Corcept Therapeutics, Inc. (CORT)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Corcept Therapeutics, Inc. (CORT)
Go deeper and ask any question about CORT
Company Performance
Current Price
as of Sep 17, 2024$39.71
P/E Ratio
35.22
Market Cap
$4.15B
Description
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Metrics
Overview
- HQMenlo Park, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCORT
- Price$39.71+3.22%
Trading Information
- Market Cap$4.15B
- Float86.08%
- Average Daily Volume (1m)642,353
- Average Daily Volume (3m)858,133
- EPS$1.22
Company
- Revenue$569.61M
- Rev Growth (1yr)39.15%
- Net Income$35.12M
- Gross Margin98.46%
- EBITDA Margin21.89%
- EBITDA$35.85M
- EV$3.15B
- EV/Revenue5.52
- P/E35.22
- P/S7.76
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset